Data / Form D filings / Retension Pharmaceuticals, Inc.
Retension Pharmaceuticals, Inc.: Form D filings
Retension Pharmaceuticals, Inc., a pharmaceuticals company in Mclean, VA, filed 3 Form D notices with the SEC between 2023 and 2025. The latest, on May 6, 2025, reports $12.3 million sold of a $20 million offering to 98 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- C/O REDUX THERAPEUTICS, LLC, 902 TURKEY RUN ROAD, Mclean, VA, 22101
- Phone
- (703) 624-2024
- Industry
- Pharmaceuticals
- Entity type
- Corporation
- Incorporated in
- Delaware
- Year incorporated
- 2023
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 2002988
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| May 6, 2025 | New notice | $20,000,000 | $12,288,567 | $7,711,433 | 98 | Apr 22, 2025 | sec.gov |
| May 15, 2024 | Amendment | $11,000,000 | $10,143,750 | $856,250 | 132 | Nov 21, 2023 | sec.gov |
| Dec 5, 2023 | New notice | $8,000,000 | $5,819,900 | $2,180,100 | 82 | Nov 21, 2023 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Eric Keller | Executive Officer, Director | |
| Michael Berendt | Director | |
| Donald Olds | Director |
Other pharmaceuticals companies in Virginia that filed recently
- Quoin Pharmaceuticals Ltd. $50 million · Sep 10, 2026
Every Form D from the week of May 5, 2025 · All recent filings in Virginia · All recent Pharmaceuticals filings
Read from SEC EDGAR. Amount sold is what Retension Pharmaceuticals, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.